secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bolt Biotherapeutics, Inc. (BOLT)
CIK:        0001641281
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0000950170-25-081607
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Bolt Biotherapeutics announces 1-for-20 reverse stock split effective June 6, 2025
--------------------------------------------------------------------------------

- Reverse stock split ratio 1:20 approved by board on May 27, 2025.
- Effective at 5:00pm ET on June 6, 2025; trading starts split-adjusted June 9.
- Ticker remains BOLT on Nasdaq Capital Market; new CUSIP 097702203.
- No fractional shares issued; cash paid in lieu of fractional shares.
- Par value unchanged at $0.00001; all shares and equity awards adjusted proportionally.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641281/000095017025081607/0000950170-25-081607-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641281/000095017025081607/bolt-20250604.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-081607

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer